Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086580
Status:
COMPLETED
Last Update Posted:
2014-03-13
First Post:
2004-07-06
Brief Title:
Fludarabine Fludara Plus Alemtuzumab CAMPATH MabCampath vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia B-CLL Patients
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-06
First Submit QC Date:
July 7 2004
Study First Post Date:
2004-07-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-08-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-10
Last Update Post Date:
2014-03-13
Last Update Post Date Type:
ESTIMATED